Arash Naeim

WISDOM: A Platform to Optimize Subtype-Specific Screening and Prevention

National Cancer Institute · P01

Project lead · $859.1K · University of California, San Francisco

UCLA Clinical and Translational Science Institute

National Center for Advancing Translational Sciences · UL1

PI · $49.1M · University of California Los Angeles

Sensing in At Risk Populations (SARP): Monitoring Performance Status, Activities of Daily Living, and Independence to Promote Safe Outcomes for Elderly Patients in Rehab, the Home and Long-Term Care

Agency for Healthcare Research and Quality · R01

Contact PI · $1.5M · University of California Los Angeles

Treatment of Older Patients with Early Breast Cancer

National Cancer Institute · K23

Contact PI · $635.9K · University of California Los Angeles

AI-Driven Consent Simplification Study

Principal investigator · Completed

University of California, Los Angeles

COVID-19 Recovered Volunteer Research Participant Pool Registry

Principal investigator · Active not recruiting

University of California, Los Angeles

Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer

Study chair · Completed · Phase 2

Translational Oncology Research International

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Site PI · Recruiting

University of California, San Francisco